Overview

Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential Hypertension

Status:
Completed

Trial end date:
2015-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to explore the optimal dose of fixed-dose combination of candesartan cilexetil and amlodipine besylate by examining the safety and efficacy of the combination therapy compared to each of the monotherapy in patients with essential hypertension.

Phase:

Phase 2

Details

Lead Sponsor:

Shin Poong Pharmaceutical Co. Ltd.

Treatments:

Amlodipine
Angiotensin II Type 1 Receptor Blockers
Angiotensin Receptor Antagonists
Candesartan
Candesartan cilexetil